KalVista Pharmaceuticals, Inc. - Common Stock, par value $0.001 per share (KALV)
CUSIP: 483497103
Q4 2017 13F Holders as of 31 Dec 2017
- Type / Class
- Equity / Common Stock, par value $0.001 per share
- Shares outstanding
- 50,580,036
- Total 13F shares
- 6,484,043
- Share change
- -1,231,248
- Total reported value
- $63,213,000
- Price per share
- $9.75
- Number of holders
- 23
- Value change
- -$2,998,314
- Number of buys
- 15
- Number of sells
- 7
Quarterly Holders Quick Answers
What is CUSIP 483497103?
CUSIP 483497103 identifies KALV - KalVista Pharmaceuticals, Inc. - Common Stock, par value $0.001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 483497103:
Top shareholders of KALV - KalVista Pharmaceuticals, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Novo Holdings A/S |
13F
|
Company |
5.4%
|
2,725,283
|
$18,341,000 | — | 30 Sep 2017 | |
| SV Health Investors, LLC |
13F
|
Company |
5.1%
|
2,579,490
|
$17,360,000 | — | 30 Sep 2017 | |
| RA CAPITAL MANAGEMENT, L.P. |
13F
|
Company |
1.2%
|
591,070
|
$4,350,000 | — | 30 Sep 2017 | |
| EVENTIDE ASSET MANAGEMENT, LLC |
13F
|
Company |
0.78%
|
396,000
|
$2,637,000 | — | 30 Sep 2017 | |
| INTERWEST VENTURE MANAGEMENT CO |
13F
|
Company |
0.65%
|
329,942
|
$2,221,000 | — | 30 Sep 2017 | |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC |
13F
|
Company |
0.64%
|
322,436
|
$2,147,000 | — | 30 Sep 2017 | |
| Vivo Capital, LLC |
13F
|
Company |
0.59%
|
300,325
|
$2,021,000 | — | 30 Sep 2017 | |
| VHCP Management II, LLC |
13F
|
Company |
0.44%
|
221,651
|
$1,492,000 | — | 30 Sep 2017 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.39%
|
199,618
|
$1,330,000 | — | 30 Sep 2017 | |
| BOOTHBAY FUND MANAGEMENT, LLC |
13F
|
Company |
0.04%
|
21,665
|
$146,000 | — | 30 Sep 2017 | |
| Alyeska Investment Group, L.P. |
13F
|
Company |
0.02%
|
11,184
|
$75,000 | — | 30 Sep 2017 | |
| FIRST QUADRANT LLC/CA |
13F
|
Company |
0.02%
|
9,250
|
$62,000 | — | 30 Sep 2017 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.01%
|
4,730
|
$32,000 | — | 30 Sep 2017 | |
| PANAGORA ASSET MANAGEMENT INC |
13F
|
Company |
0%
|
2,274
|
$15,000 | — | 30 Sep 2017 | |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE |
13F
|
Company |
0%
|
231
|
$2,000 | — | 30 Sep 2017 | |
| Valeo Financial Advisors, LLC |
13F
|
Company |
0%
|
142
|
$1,000 | — | 30 Sep 2017 |
Institutional Holders of KalVista Pharmaceuticals, Inc. - Common Stock, par value $0.001 per share (KALV) as of Q4 2017
As of 31 Dec 2017,
KalVista Pharmaceuticals, Inc. - Common Stock, par value $0.001 per share (KALV) was held by
23 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
6,484,043 shares.
The largest 10 holders included
SV Health Investors, LLC, RA CAPITAL MANAGEMENT, LLC, EVENTIDE ASSET MANAGEMENT, LLC, INTERWEST VENTURE MANAGEMENT CO, INTERNATIONAL BIOTECHNOLOGY TRUST PLC, Vivo Capital, LLC, MILLENNIUM MANAGEMENT LLC, NEXTHERA CAPITAL LP, Vanguard Group Inc, and RENAISSANCE TECHNOLOGIES LLC.
This page lists
23
institutional shareholders reporting positions in this security
for the Q4 2017 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2017 vs Q3 2017 Across Filers
Q3 2017 holders
15
Q4 2017 holders
23
Holder diff
8
| Investor | Q3 2017 Shares | Q4 2017 Shares | Share Diff | Share Chg % | Q3 2017 Value $ | Q4 2017 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.